Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Eisai Opens New Subsidiary In U.K.

March 12, 2007 | A version of this story appeared in Volume 85, Issue 11

The Japanese drug company Eisai has established a European manufacturing subsidiary in Hatfield, north of London. The subsidiary, the company's first European production facility, will also provide quality assurance and supply-chain management in Europe. The plant will be part of a $200 million European Knowledge Center, expected to house Eisai's regional headquarters, discovery and clinical research, production, and marketing functions. The company will maintain its current R&D facilities at University College London, officials say.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.